Tenapanor
Back to searchMolecule Structure
Scientific Name
Tenapanor
Description of the Drug
Tenapanor is an NHE3 inhibitor indicated for the treatment of constipation-predominant irritable bowel syndrome (IBS-C).
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11761
http://www.drugbank.ca/drugs/DB11761
Brand Name(s)
Not Available
Company Owner(s)
Ardelyx Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Sodium/hydrogen exchanger 3 | SINGLE PROTEIN | INHIBITOR | CHEMBL3273 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL15267600 | |
DrugBank | DB11761 | |
PubChem | 71587953 | |
Nikkaji | J3.655.031G | |
BindingDB | 381823 | |
EPA CompTox Dashboard | DTXSID40154016 | |
DrugCentral | 5349 | |
ChemicalBook | CB93038513 | |
Guide to Pharmacology | 8449 | |
rxnorm | TENAPANOR | TENAPANOR HYDROCHLORIDE |